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The selection of themost relevantmolecular descriptors to describe a target variable in the context ofQSAR (Quantitative Structure-
Activity Relationship) modelling is a challenging combinatorial optimization problem. In this paper, a novel software tool for
addressing this task in the context of regression and classification modelling is presented. The methodology that implements the
tool is organized into two phases. The first phase uses a multiobjective evolutionary technique to perform the selection of subsets
of descriptors. The second phase performs an external validation of the chosen descriptors subsets in order to improve reliability.
The tool functionalities have been illustrated through a case study for the estimation of the ready biodegradation property as an
example of classification QSAR modelling. The results obtained show the usefulness and potential of this novel software tool that
aims to reduce the time and costs of development in the drug discovery process.
1. Introduction
Molecular Informatics is an emerging interdisciplinary that
addressesmathematical and computational problems, related
to molecule-based information encoding and processing,
oriented to the discovery of new knowledge in several fields
as pharmacology, material engineering, or environmental
sciences [1–4] In particular, Quantitative Structure-Activity
Relationships (QSAR) modelling constitutes active area of
research in Molecular Informatics. QSAR models have been
proposed in order to estimate several biological properties,
such as activity [5, 6] or ADMET properties [7, 8], providing
relevant information to support drug discovery projects
[9, 10]. The advantages of having QSAR models for drug
design are numerous: reduction of the time spent during
the discovery phase, reduction of economic and material
resources required due to a decrease in the number of
traditional tests, reduction of animal testing, among others.
During the last years, the sizes of chemical com-
pound databases have expanded considerably. However, this
abundance in the availability of data has not been able
to avoid the growth of the failure rate in the preclinical
phases and the “attrition rate”, that measure the proportion
of candidate compounds to constitute new drugs that are
discarded during the different phases of a drug design project
[11]. In this sense, having accurate QSAR models can help
improve these issues.
QSAR studies require the codification of the chemical
structure of compounds by a diversity of molecular descrip-
tors [12], such as constitutional, geometrical, functional
groups, topological, thermodynamic, and quantummechani-
cal. Currently, the development of new cheminformatics soft-
ware allows calculating thousands of molecular descriptors,
but usually only a small subset of these descriptors brings
necessary information for obtaining the QSAR model of
interest [13]. Subsequently, the precision of these models rests
on the correct selection of molecular descriptors used during
the QSAR model generation [14].
Severalmachine learning approaches have been proposed
for addressing the selection of molecular descriptors in an
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Figure 1: Representative scheme of descriptor selection process.
automatic [15] or semiautomatic fashion [16], which are usu-
ally known in computer science as feature selection methods.
This complex task can be characterized as a multiobjective
combinatorial optimization problem,where several subsets of
molecular descriptors are alternatively selected and evaluated
in terms of different optimization criteria [17]. In general,
subsets which achieve high predictive accuracy and low
cardinality are usually preferred by QSAR model designers
[14]. Multiobjective techniques have various uses in QSAR,
such as (1)multiobjective optimization of drugs [18–22], (2)
development of multitarget models [23–25], (3) multiscale
modelling [26–28], (4) chemical, preclinical, omics, and
epidemiological data fusion [29–33], and (5) multiobjective
feature selection [34–36]. Some authors have worked on the
four first applications mentioned before, for instance, the
multiobjective method Perturbation-Theory Machine Learn-
ing (PTML) with applications in cheminformatics, nanotech-
nology, omics, and pharmacoepidemiology [37]. However,
there are not many reports of multiobjective approaches for
feature selection in this area.
In Soto et al. [38], a multiobjective feature selection
method for prioritization of molecular descriptors subsets
in QSAR studies is presented. The proposed algorithm is
organized as a two-phase methodology. The first one makes
use of a multiobjective evolutionary technique that yields
interesting advantages compared to monoobjective feature
selection methods [39]. The second phase enables refining
and improving the confidence in the chosen descriptors
subsets. This methodology allows the selection of subsets
when a large number of descriptors are involved and it
is also suitable for linear and nonlinear QSAR regression
models.
Later, a software tool, named as DELPHOS, was imple-
mented based on this two-phase methodology [40]. This
tool has been successfully applied in the development of
regression models for predicting a wide variety of proper-
ties [41–44]. Nevertheless, some drawbacks and limitations
are present in DELPHOS. First of all, the computational
methodology behind this software has only been designed
for selecting descriptors in the context of QSAR regression
models, but feature selection for QSAR classification models
has not been considered. Another drawback is related to the
evolution of the state-of-art of machine learning methods,
because during the last decade new promising approaches
have been proposed in the literature. In this sense, the same
machine learning methods used in different steps of the two-
phase feature selection methodology can be updated to more
robust methods such as Random Forest [45, 46] or Random
Committee [47] methods. Finally, DELPHOS was codified
using proprietary software [48]. Lamentably, this decision
presented some disadvantages because new versions of the
proprietary software are not fully compatible with the version
used for programming the tool, and the use of DELPHOS
code is limited to license holders of this proprietary software.
In this paper, a novel software tool, called MoDeSuS (for
Molecular Descriptors Subsets Selection), is presented. This
new feature selection tool was designed in order to address
all DELPHOS limitations explained above, which constitutes
the main contribution of this work. Additionally, a case study
for QSAR modelling in the context of classification problems
for drug properties estimation is presented for illustrating
the software application in pharmacology. Finally, an integral
view of all functionalities and advantages of using MoDeSuS
for drug design projects is discussed in conclusion of this
article.
2. Materials and Methods
2.1. QSAR Modelling and Feature Selection. QSAR models
establish relationships between some structural characteris-
tics of a chemical compound and a specific physicochemical
or biological property of interest [1]. QSAR models can
be inferred through supervised learning processes, using
compounds databases for which the experimental values
of the target variable to be modelled are already known.
Usually, the inference of these models is done using machine
learning strategies that require the addressing of several
computational subproblems [49]. Among them is the process
of selecting the most relevant molecular descriptors for the
modelling of the target variable [14], illustrated in Figure 1,
which is a particular case of the problem of feature selection.
A database containing compounds, molecular descriptors,
and a target variable to be modelled is required to carry out
this combinatorial process of descriptor selection. Then, a
machine learning strategy is applied to select and evaluate
different subsets of descriptors in order to identify a reduced
group of them.
2.2. Feature Selection as Multiobjective Combinatorial Opti-
mization. The methodology presented in [38] implements a
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Figure 2: DELPHOS two-phase feature selection methodology.
multiobjective optimization method, based on two phases,
in order to identify subsets of descriptors relevant to the
target variable. The first phase makes use of multiobjective
combinatorial optimization and acts as a coarse selector of
descriptors subsets, while the second phase performs an
accurate evaluation of the subsets of the last general selection.
Figure 2 shows an overview of the two-phase methodology.
First phase is as follows: as shown in Figure 2, a wrapper
method can be divided into two parts: Feature Searching and
Feature Subset Evaluation. The first is responsible for con-
ducting the combinatorial search between different selections
of feasible subsets. In this sense, binary vectors were used to
represent individuals. Each vector has n components, that is,
one bit for each available descriptor. A nonzero value in the
ith bit position of the vector indicates that the ith descriptor is
chosen within the selection of the individual. In contrary, a
null value in the ith bit position of the vector indicates that
the ith descriptor is not chosen within the selection of the
individual. The second part evaluates the usefulness of the
selected subset and in this way guides the Feature Searching
in the selection of the most relevant descriptors. In this
sense, in the Feature Searching two different approaches were
applied: aggregation and Pareto. In the first one, the searching
is guided by a formula that combines two objectives in order
to evaluate the relevance of each subset of descriptors. The
first objective function F1 calculates the number of selected
descriptors. The second objective function F2 estimates the
predictive accuracy of a method using the selected descrip-
tors; more precisely, this function computes the mean square
error of prediction applied to a set of compounds not used for
training. In particular, aggregation allows multiple objectives
to be combined into a single fitness function. From the F1 and
F2 functions, the following proposed aggregation formula
arises:
𝐹𝐴𝐺 = 𝛼𝐹2 + (1 − 𝛼) 𝐹2
𝐹1
𝑝𝑚
(1)
In (1), 𝛼 is a weighting parameter for each objective with
possible values in the interval [0, 1], and 𝑝𝑚 is a parameter
that represents the maxima cardinality of a subset. On the
other hand, the Pareto based techniques (NSGA II and
SPEA 2) optimizes the objectives separately according to the
concept of dominance. Dominance is a partial order that can
be established between vectors defined over a space Rk, where
k is the number of objectives to be optimized. In this case,
since we have two functions (F1 and F2), the defined space
is R2. From the definition of dominance, the term Pareto
front is derived, which is the set of optimal solutions within
the problem space and the nondominated front contains the
solutions found that are not dominated by any other solution.
Second phase is as follows: after applying a combination
of any feature search method and evaluation for the multiob-
jective wrapper, a front of nondominated individuals of each
execution is formed. All nondominated subsets obtained in
the same run are treated as the set of the most interesting
solutions found by the wrapper in that run. Each subset of
descriptors in the front is evaluated by a validation method;
in particular a set of artificial neural networks (ANNE) was
used.
2.3. Machine Learning Methods for Regression and Classi-
fication. Linear regression is a mathematical method that
models the relationship between an output variable (y),
independent variables (xi), and a random error term (𝜀). In
the case of simple regression, we have a single independent
variable x, x ∈ R. Multiple linear regression is an extension of
the simple one where the independent variable x is a vector,
such that x ∈ Rn.
Regression trees are decisions trees applied to regression
problems. In this sense, each internal node of the tree
represents a condition (for example, if the feature value
exceeds or not a certain threshold) and each leaf denotes
the function of regression to be used. The coefficients of this
regression functionwill be the features that guided the path to
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that leaf. Further, provide a mechanism for pruning and thus
keep the minimum height of the tree avoiding overfitting.
Neural Networks (multiperceptron) method classifies
instances through backpropagation. This network can be
monitored and modified during training time. The nodes in
the network are all sigmoid (except for when the class is
numeric in which case the output nodes become unthresh-
olded linear units).
k-nearest neighbours method consists of assigning the
instance to classify the majority label among the nearest k
neighbours. The measure most commonly used to measure
closeness is the Euclidean distance.
Random Forest generates a forest of random trees [46].
This arbitrary set of independent decision trees is tested on
random datasets that have the same number of variables
selected at random, performing no pruning. Also, it has
an option to allow estimation of class probabilities (or
target mean in the regression case) based on a hold-out set
(backfitting).
Random Committee builds an ensemble of randomized
base classifiers. Each base classifier is built using a different
random seed. The final predict value is a straight average of
the predictions generated by the individual base classifiers.
In decision trees, the data is recursively divided into
smaller sets with binary partitions. In each iteration of the
method, different partitions are evaluated (evaluating the
whole dataset) and the best one is chosen. The division of the
data generates as output of themethod a tree structure, where
each node represents one of the input variables. Each leaf
node in the tree represents a value of the destination variable.
That is, the predicted value of the destination variable is
obtained by the path traveled from the root to a leaf of the
tree.
2.4. Molecular Information Datasets for Case Studies. The
dataset used for the classification case study was extracted
from [50]. It consists of 1725 molecules, 1480 molecular
descriptors calculated by using Dragon [51], and the exper-
imental values of the target variable: ready biodegradation.
These values have been reported after performing a test that
measures the biochemical oxygen demand (BOD). In this
sense, chemical compounds with a BOD value greater than
60% are considered ready biodegradation (RB) and those
with a BOD value of less than 60% are considered not ready
biodegradation (NRB). Of the totalmolecules, 1055 were used
for the feature selection process and the remaining 670 were
used to perform an external validation process.
2.5. Random Experiments Methods for Validation. In order
to evaluate the risk of a random correlation in a subset of
selected molecular descriptors, an fs-randomization (feature
selection randomization) technique was used. This method
consists of randomly selecting a set of descriptors (with the
same cardinality of the subset selected by a specific technique)
from the original set of features. With these descriptors
and the property original values, a new model is generated
with the same experimental criteria that were used to obtain
the final QSAR model. Finally, the percentage of correctly
classified cases (%CC) and the Matthews Correlation Coef-
ficient (MCC) are reported. This procedure is executed a
considerable number of times in order to obtain a distribution
of values with statistical significance.
A similar procedure was performed to evaluate the
random correlation of the final QSAR model inferred from a
set of descriptors using y-randomization [52].This technique
randomly reorders the property values (y-variable) and leaves
the selected molecular descriptors intact. In this way, a new
model is inferred using the molecular descriptors of the final
QSAR model and under the same experimental conditions
but with the reordered values of the property. Like fs-
randomization, this process is repeated a significant number
of times, reporting the percentage of correctly classified cases
(% CC) and the Matthews Correlation Coefficient (MCC)
each time.
3. Results and Discussion
In this section, details of the modifications made to the two-
phase method developed by Soto et al. will be provided [38].
Also, the MoDeSuS functionalities will be explained and
finally a case study in the context of classification problems
for QSAR modelling will be presented in order to illustrate
the software application in pharmacology.
3.1. MoDeSuS Tool. As mentioned above, MoDeSuS relies
on the methodology presented in [38] that implements a
multiobjective optimization based on two phases with some
modifications introduced to contemplate classification prob-
lems and update themachine learningmethods used. Figure 3
shows an overview of MoDeSuS two-phase methodology.
In the first phase, two significant changes were made. One
of them was to introduce a modification in the aggregation
formula to allow dealing with classification problems. In this
sense, the formula of (1) is still used, but in this case the
objective function F2 changes depending on whether it is a
regression or classification problem. That is, in the context
of regression, F2 continues to estimate the mean square
error of prediction, but in the classification context, F2 will
now compute the percentage of cases that were not correctly
classified by the predictor. The other change made is related
to the machine learning methods provided. It can be seen in
Figure 3 that the tool provides a wide variety of methods for
both regression and classification problems. Finally, in the
second phase an external validation of the selected subsets
is carried out using one of three possible machine learning
methods: Random Forest, Random Committee, and Neural
Networks.
3.2. Software Functionalities. MoDeSuS provides a graphical
interface allowing the user to use the software without
needing to know specific details of the code or of the
different methods applied and a variety of features that will
be explained below and can be summarized in Figure 4.
Data handling contains the functions for data loading.
The input data must be in the CSV file format. The size of the
entered data is verified and the computation results of each
phase can be saved and restored later.
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Feature searching and evaluation is themodule that carries
out the multiobjective evolutionary wrapping method of the
first phase. The user can configure all the parameters of this
phase, for example, the parameters of the evolutionary algo-
rithm, and also select the automated learning method with
which the different subsets of descriptors will be evaluated.
Feature validation provides the functionalities to config-
ure parameters and execute the second phase of the method.
Statistical results are the module through which the
user visualizes and interacts with the results obtained from
the second phase. It is possible to access the information
of the descriptors subsets that have been selected as well
Figure 5: MoDeSuS initial view.
as different statistical metrics depending on the problem
being addressed (regression or classification). In addition, the
option of filtering the data is available, that is, choosing a
specific subset and saving it.
3.3. Case Study and Performance Assessment. In this section,
a case study in the context of classification problems to illus-
trate in detail the use of MoDeSuS in pharmacology will be
explained.Theproperty under study corresponds to the ready
biodegradation of chemical compounds.When executing the
tool several options will be available (Figure 5). There is the
possibility of executing each phase separately or executing
both phases sequentially. This last option was chosen to carry
out our study. The results are shown immediately or can be
consulted later with the option provided for that purpose.
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Figure 6: MoDeSuS data loading.
Figure 7: MoDeSuS data loading verification.
When choosing the “First and Second Phase” option, a
data loading window will be displayed (Figure 6). In this
window, a file inCSV format containing the values and names
of the molecular descriptors and the class labels for ready
biodegradation was loaded. In addition, it must be specified
if the CSV file separator is a comma or a semicolon.
After data loading, another window will be displayed
(Figure 7) in order to verify the data size. In our study a
database with 1055 compounds and 1480 molecular descrip-
tors was used.
When verifying that the data size is correct, the execution
continues displaying the first phase parameters configuration
window (Figure 8).These parameters will have default values
that the user can change according to their needs. In case
there is an error in the loaded data, it is possible to go back and
carry out the data loading again. It is important to mention
that before starting the execution of the search algorithm,
the tool performs an analysis of the data eliminating those
variables with constant value. In this way, the number of
Figure 8: MoDeSuS first phase.
descriptors loaded initially can be reduced before executing
the first phase.
In Figure 8, it can be seen the parameters configuration
used for our experiment. This window consists of three main
sections. In the General Settings section, it is possible to
define the percentage of internal validation, the percentage of
external validation, and the seed. These values are necessary
to determine the data partitions that will be used in each
phase: one set of data for internal validation (to be used in
the first phase) and another set of data remaining for external
validation (to be used in the second phase). The seed value
can be changed to perform different data partitions.
In the Wrapper Configuration section, it is possible to
configure all the parameters that the wrapping method needs
to perform the search. In this sense, the trialsparameter refers
to the number of final subsets that will be generated, the alpha
value refers to the value “𝛼” that is part of the aggregation
formula (see (1)) and that will establish the weight that
will be given to each objective function, and the maximum
cardinality of the descriptors subsets. In addition, there are
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Figure 9: MoDeSuS second phase.
two lists of machine learning methods for regression and
classification. The method selected will be the one used to
estimate the predictive capacity of the descriptors subsets.
In GA Settings section, it is possible to configure all
the parameters associated with the evolutionary method.
It is possible to determine the size of the population (the
number of individuals participating in each generation of the
algorithm), the size of the elite (the number of individuals
that are preserved from one generation to the next), the
size of the tournament (the number of individuals competing
in a tournament), the probability that two individuals will
recombine (PXO), and the probability that an individual will
suffer a mutation (PMut). In addition, stop criteria are set,
such as the maximum number of generations that can be
executed (#Gens), the maximum number of consecutive gen-
erations during which the average fitness of the population
may not show significant improvements (Stall Gens), and
the threshold (Stall Threshold) that defines the minimum
(positive) difference that must exist between the average
fitness of the population of one generation and the next to
consider that there was improvement. Finally, the file name
for saving the search results must be defined. This file will be
used later for the execution of the second phase (Figure 9)
whose window becomes visible once the execution of the first
phase has finished.
In Figure 9 the parameters used in our case study are
shown. It is possible to choose the number of subsets to
evaluate and the machine learning method. This external
validation will be carried out with the percentage of data that
was set in the window of the first phase (Figure 8). Finally, the
file name for saving the evaluation results must be defined.
This file will be used for the results view.
Once the execution of the second phase is finished,
the results window will be displayed (Figure 10). In this
window two different views of the selected subsets and
different options of statistical metrics can be seen that can
be visualized through the graphics. These metrics are as
Table 1: Performances of the three subsets with higher accuracy
predictive obtained by using MoDeSuS. The percentage of cases
correctly classified (%CC), the Average Receiver Operating Char-
acteristic (ROC), theMatthews Correlation Coefficient (MCC), and
the cardinality are reported.
Metrics Subset 1C Subset 2C Subset 3C
%CC 84 81 81
ROC 0.89 0.88 0.87
MCC 0.7 0.66 0.64
Cardinality 15 15 15
follows: the percentage of cases correctly classified, the Aver-
age Receiver Operating Characteristic (ROC), the Matthews
Correlation Coefficient (MCC), and the cardinality. In this
case, Figure 10 shows the results for the 10 subsets of
descriptors that were selected for the ready biodegradation
property.
By pressing each button corresponding to the different
statistical metrics, each of the graphs will be displayed.
Figure 11 shows the graphs corresponding to the percentage
of cases correctly classified (% CC) and the Average Receiver
Operating Characteristic (ROC), respectively. For our study
we decided to stay with the three best subsets of the 10
reported byMoDeSuS and with them perform a final external
validation stage with 670 compounds. Table 1 shows a sum-
mary of metrics for the three subsets with higher accuracy
predictive.
With the three subsets reported in Table 1, an external
validation process using the 670 compounds for testing was
performed using Weka [53] in the following way: for each
subset (Subset 1C, Subset 2C, and Subset 3C) 10 runs were
made using Random Forest (the same machine learning
method that was used during the descriptor selection stage)
with different seed values. The predictive accuracy for each
subset can be seen in Table 2. The best performance was
obtained for Subset 1C (shown in bold in Table 2) with 87% of
correctly classified cases, a Matthews Correlation Coefficient
of 0.67, a precision value of 0.87, and a recall value of 0.87 on
average.
Based on the results shown in Table 2, it is recommended
to use themodel learned from the descriptors of Subset 1C for
future predictions on new data. The performance achieved
by this model is slightly lower than that reported by [50]
(precision: 0.94 and recall: 0.81). In this sense, it is important
to clarify that the performance obtained by [50] was achieved
by filtering 13% of the external validation compounds using
applicability domain techniques and constructing the model
through consensus with a number of descriptors significantly
greater than that of Subset 1C. In this sense, it is important
to highlight that the specific objective of this case study is
to illustrate the application of MoDeSuS on a dataset already
used, in order to find a set of molecular descriptors that
generate models with high predictive precision and with a
low number of descriptors, both conditions that are defined
in the tool through the fitness function of the evolutionary
algorithm.
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Figure 10: MoDeSuS results view.
Table 2: Predictive accuracy of external validation process over subsets 1C, 2C, and 3C by using Weka. The percentage of cases correctly
classifies (%CC), the Matthews Correlation Coefficient (MCC), precision (PR), and recall (RC) values is reported.
Subset 1C Subset 2C Subset 3C
Run %CC MCC PR RC %CC MCC PR RC %CC MCC PR RC
1 86.12 0.65 0.86 0.86 83.28 0.57 0.83 0.83 84.77 0.61 0.84 0.85
2 86.86 0.67 0.87 0.87 83.43 0.57 0.83 0.83 85.37 0.63 0.85 0.85
3 86.41 0.66 0.86 0.86 83.13 0.57 0.83 0.83 85.52 0.63 0.85 0.86
4 86.86 0.67 0.86 0.87 82.53 0.55 0.82 0.83 84.77 0.61 0.84 0.85
5 87.46 0.68 0.87 0.88 83.43 0.56 0.83 0.83 84.62 0.61 0.84 0.84
6 87.31 0.68 0.87 0.87 84.47 0.6 0.84 0.85 85.22 0.63 0.85 0.85
7 87.46 0.68 0.87 0.88 83.43 0.58 0.83 0.83 85.07 0.62 0.85 0.85
8 85.97 0.65 0.86 0.86 82.98 0.57 0.83 0.83 85.67 0.64 0.85 0.86
9 87.31 0.68 0.87 0.87 82.23 0.54 0.82 0.82 84.62 0.61 0.84 0.85
10 87.61 0.69 0.87 0.88 82.23 0.54 0.82 0.82 85.07 0.62 0.85 0.85
Avg. 87.00 0.67 0.87 0.87 83.00 0.57 0.83 0.83 85.00 0.62 0.85 0.85
3.4. Random Experiments. In this section, two experiments
will be presented in order to evaluate the risk of a ran-
dom correlation in both the final descriptors subset chosen
(Subset 1C) and in the final QSAR model inferred from
these molecular descriptors. In this sense, the first aspect to
evaluate is whether the Subset 1C selected by MoDeSuS has
a significantly high predictive accuracy than other subsets
of descriptors (of the same cardinality) randomly selected.
Then, in a second instance, the final QSARmodel is evaluated
in order to ensure that it is not classifying compounds
randomly.
In the first instance, a feature selection randomization
(fs-randomization) was carried out in the following way: a
thousand combinations of fifteen descriptors were randomly
selected from the initial set of 1480 molecular descriptors.
Then, for each random subset, a new QSAR model was
learned under the same experimental conditions as the final
QSAR model, finally reporting the %CC and MCC values.
Table 3 shows the results obtained. For the case of %CC, the
mode is 79.85 with a variance value of 8.81. In addition, 99%
of the %CC values obtained by fs-randomization are below
86.71 and the final QSARmodel inferred from the descriptors
obtained by MoDeSuS (Subset 1C) reported 87% of correctly
classified cases, showing a significantly higher performance
than the subsets random. In the case of MCC, the mode is
0.53, the variance is 0.01, and 99% of the values reported by
fs-randomization are below 0.66. The MCC value reported
by the final QSAR model was 0.67, again overcoming the
predictive capacity of the random subsets.
As a next step, a y-randomization experiment has been
executed. This technique is probably considered as the most
powerful form of validation to evaluate the risk of chance
correlation in QSAR models [54] and also when combined
with the experimentation fs-randomization allows ensuring
the reliability of QSAR models [53]. For this purpose, the
values of the property are mixed randomly (both in the
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Figure 11: MoDeSuS graphics: (a) Percentage of Cases Correctly Classified (%CC) and (b) Average Receiver Operating Characteristic (ROC).
training and in the external validation set) leaving intact the
Subset 1C descriptors obtained byMoDeSuS. This procedure
is repeated a thousand times, and each time a new QSAR
model is generated following the same experimental con-
ditions as the final QSAR model and the values of % CC
and MCC are reported. In Table 3 the metrics obtained are
reported. For the%CC, themode is 63.73, the variance is 4.10,
and 99% of the values reported by y-randomization are less
than 68.05. In the case ofMCC, the mode is 0.03, the variance
of 0.001 and 99% of the values reported by the experiment
is less than 0.09. In this sense, it is possible to observe that
the performance obtained by the model inferred from the
descriptors of Subset 1C is significantly higher than the yields
obtained through y-randomization. Consequently, according
to the results of the two experiments, it is possible to discard
safely the risk of correlation by chance in the final QSAR
model learned with the descriptors selected by MoDeSuS.
4. Conclusions
In this paper, a novel software tool for selection of molecular
descriptors subsets in QSAR modelling is presented. This
new feature selection tool, named MoDeSuS, was designed
in order to address this task for regression and classification
problems. The computational methodology behind MoD-
eSuS is organized as a two-phase procedure. The first one
10 BioMed Research International
Table 3: Statistical results for fs-randomization and y-randomization and performance of the model inferred from descriptors of Subset 1C
(ModelSubset1C). For each case, for the percentage of cases correctly classified (%CC) and the Matthews Correlation Coefficient (MCC), three
metrics are reported: mode, variance, and percentile99.
fs – randomization
𝑀𝑜𝑑𝑒𝑙𝑆𝑢𝑏𝑠𝑒𝑡1𝐶Mode Variance Perc(99)
%CC 79.85 8.81 86.71 87
MCC 0.53 0.01 0.66 0.67
y – randomization
𝑀𝑜𝑑𝑒𝑙𝑆𝑢𝑏𝑠𝑒𝑡1𝐶Mode Variance Perc(99)
%CC 63.73 4.10 68.05 87
MCC 0.03 0.001 0.09 0.67
makes use of a multiobjective evolutionary technique that
identifies promising subsets of molecular descriptors follow-
ing a wrapper technique. The second phase complements the
first one and it enables refining and improving the confidence
in the chosen subsets of descriptors by using complex
machine learning methods: Random Forest and Random
Committee. Additionally, several visualization modes for the
different metrics reported for classification and regression
modelling are included in the software.
MoDeSuS facilities and functionalities had been illus-
trated by using the tool in a cases study that constitutes
an example for classification QSAR modelling, where the
estimated property corresponds to ready biodegradation of
chemical compounds. Comparisons with the performance
achieved by others QSAR studies had been discussed, show-
ing the potentially and usefulness of this novel software. For
that reason, we think that MoDeSuS can constitute a valuable
tool for QSAR modelling practitioners, helping to reduce
time and money costs in drug development projects.
As future work, we plan to extend our software tool for
considering the applicability domain of the QSAR models,
evolved from the different subsets of selected molecular
descriptors recommended by MoDeSuS, as an additional
performance metric. The applicability domain estimation is
a key issue in QSAR modelling, because the generalizability
of the models depends on it. This goal can be achieved
by integrating, in the fitness function of the evolutionary
algorithm, information about the applicability domain of the
QSARmodels generated by each subset of selected molecular
descriptors explored during the first phase of MoDeSuS.
In this way, the feature selection will not only produce
accurate and interpretable QSAR models, but also ensure
enhanced generalizability on new data, deriving in more
reliable predictions.
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